Sichuan Kelun Pharma's Purchase of 20% Stake in Lijun International Pharma is Off

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

November 1, 2013 -- Sichuan Kelun Pharmaceutical will not acquire a 20% stake in Lijun International Pharma (HK: 2005), a transaction that was previously announced in December of last year. No reason for the reversal was given. At the time of the original announcement, Kelun said it would pay $135 million to buy the stake from two major Lijun shareholders. More details....

Stock Symbol: (SHE: 002422)

Help employers find you! Check out all the jobs and post your resume.

Back to news